Company Presentation • 14 Nov 2025 10:00
Q3 2025
Company Presentation • 24 Aug 2026 20:30
Q2 2026
Company Presentation • 27 Aug 2021 15:30
H1 2021
Company Presentation • 21 Aug 2020 15:30
H1 2020
Company Presentation • 24 Apr 2020 11:30
𝛼SK or SearchENTITY
InnoCare Pharma (9969 HK)
InnoCare Pharma (9969 HK)
120
Analysis
Health Care • China
InnoCare Pharma is a commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing drugs for cancer and autoimmune diseases. Its pipeline includes key products like orelabrutinib, tafasitamab, and ICP-332. The company was co-founded in 2015 and is headquartered in Beijing, China.
morex